⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16294643 | 0.75 | — | — | |
| SCHEMBL9681629 | 0.75 | — | — | |
| SCHEMBL9681638 | 0.75 | — | — | |
| SCHEMBL14049460 | 0.75 | — | — | |
| SCHEMBL16294994 | 0.75 | — | — | |
| SCHEMBL9062787 | 0.75 | — | — | |
| SCHEMBL27888 | 0.75 | — | — | |
| SCHEMBL17379189 | 0.75 | — | — | |
| SCHEMBL2902537 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL15651592 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115135656-B | Furanoindazole derivatives | 拜耳公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2024083705-A1 | FUROINDAZOLE DERIVATIVES FOR THE TREATMENT OF PAIN | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-25 | — | — | WO | claimed |
| US-20230112499-A1 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-04-13 | — | — | US | claimed |
| WO-2021122415-A9 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-30 | — | — | WO | claimed |
| WO-2021122415-A1 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-06-24 | — | — | WO | claimed |
| US-9018311-B2 | Copolymer | NIPPON SODA CO., LTD. (JP) | 2015-04-28 | — | — | US | claimed |
| CN-115135656-B | Furanoindazole derivatives | 拜耳公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2024083705-A1 | FUROINDAZOLE DERIVATIVES FOR THE TREATMENT OF PAIN | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-25 | — | — | WO | disclosed |
| EP-3645592-B1 | TETRAHYDROFURFURYL ALCOHOL INITIALIZED POLYETHERAMINES AND USES THEREOF | HUNTSMAN PETROCHEMICAL LLC (US) | 2023-04-19 | — | — | EP | disclosed |
| US-20230112499-A1 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-04-13 | — | — | US | disclosed |
| WO-2021122415-A9 | FUROINDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-30 | — | — | WO | disclosed |
| CN-110573546-B | Tetrahydrofurfuryl alcohol-initiated polyetheramines and their use | 亨斯迈石油化学有限责任公司 | 2022-05-10 | — | — | CN | disclosed |
| US-20210284796-A1 | TETRAHYDROFURFURYL ALCOHOL INITIALIZED POLYETHERAMINES AND USES THEREOF | HUNTSMAN PETROCHEMICAL LLC | 2021-09-16 | — | — | US | disclosed |
| EP-2617746-A1 | NOVEL COPOLYMER | Nippon Soda Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-8481574-B2 | (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants | ABBOTT LABORATORIES (US) | 2013-07-09 | — | — | US | disclosed |
| US-20080255123-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2008-10-16 | — | — | US | disclosed |
| WO-2008063781-A2 | CHEMICAL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2008-05-29 | — | — | WO | disclosed |
| EP-0051819-B1 | TETRA-SUBSTITUTED BENZENE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1985-02-13 | — | — | EP | disclosed |
| EP-0051819-A2 | Tetra-substituted benzene derivatives, their preparation and pharmaceutical preparations containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-05-19 | — | — | EP | disclosed |
| US-4323684-A | IN A POLAR SOLVENT | ADEKA ARGUS CHEMICAL CO., LTD. | 1982-04-06 | — | — | US | disclosed |